SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-135471
Filing Date
2016-11-21
Accepted
2016-11-21 06:27:32
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v452348_10q.htm 10-Q 353117
2 EXHIBIT 31.1 v452348_ex31-1.htm EX-31.1 10624
3 EXHIBIT 31.2 v452348_ex31-2.htm EX-31.2 10644
4 EXHIBIT 32.1 v452348_ex32-1.htm EX-32.1 3684
5 EXHIBIT 32.2 v452348_ex32-2.htm EX-32.2 3921
  Complete submission text file 0001144204-16-135471.txt   2804858

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rasp-20160930.xml EX-101.INS 613785
7 XBRL TAXONOMY EXTENSION SCHEMA rasp-20160930.xsd EX-101.SCH 27180
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rasp-20160930_cal.xml EX-101.CAL 19568
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rasp-20160930_def.xml EX-101.DEF 152715
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rasp-20160930_lab.xml EX-101.LAB 201408
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rasp-20160930_pre.xml EX-101.PRE 190245
Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-191083 | Film No.: 162009023
SIC: 2834 Pharmaceutical Preparations